Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Present at BIO-Europe Spring|March 18–20, 2024|Booth #34

Creative BioMart Decided to Enhance Facilities for Biosimilar Comparability Study Services

Creative BioMart, a world leading biotech company that specialized in providing protein, recombinant protein, GMP protein, cell line and protein-related services, decided to enhance its facilities for biosimilar comparability study services.

The current guidelines for biosimilar allow a reduced drug development programme, making entry to the market much faster for biosimilar manufacturers. Although the pathway to licensure for biosimilar is reduced when compared to that of a new product, these cannot be considered identical to the innovator product and a number of assessments are required to demonstrate comparability.
 
“For a corporate to survive in fierce competition, the first thing it should do is enhancing itself. Introducing advanced techniques, gathering elite professional, improving corporate culture are all key factors.” said chief marketing staff Linna Green in Creative BioMart. “Based on the current biosimilar study services we have, we decided to allocated 3 million dollars to introducing the latest technique and employ more experts in biosimilar study” Linna Green added.

Visit
http://www.creativebiomart.net/Biosimilar-Comparability-Studies.htm to know more about Creative BioMart’s current biosimilar comparability study services and to follow its update.
 
Article Link: Creative BioMart Decided to Enhance Facilities for Biosimilar Comparability Study Services
Tags: Biosimilar Comparability Study, creative biomart

Related Press Release :

logo

FOLLOW US

Terms and Conditions        Privacy Policy

Copyright © 2024 Creative BioMart. All Rights Reserved.

Contact Us

  • /

Stay Updated on the Latest Bioscience Trends